Projections of the Non-Retail Prescription Drug Share of National Health Expenditures

Report | July 01, 2022 | Charles Roehrig and Ani Turner

This data brief augments the Centers for Medicare & Medicaid Services (CMS) projections of national health expenditures by estimating non-retail prescription drug spending – spending on drugs administered in hospitals, clinics, or nursing homes that CMS captures in spending on these services – to form a projection of total (retail plus non-retail) drug spending as a share of national health expenditures. 

Download the report to learn our projection of non-retail and total drug spending from 2020 to 2030, as well as an explanation of our methods. 


View Related: Economics, Health Care Value